LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors’s Novavax NVAX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59K | Hold |
570
| – | – | ﹤0.01% | 504 |
|
|
2025
Q1 | $4.26K | Hold |
570
| – | – | ﹤0.01% | 511 |
|
|
2024
Q4 | $5.31K | Hold |
570
| – | – | ﹤0.01% | 508 |
|
|
2024
Q3 | $5.65K | Hold |
570
| – | – | ﹤0.01% | 522 |
|
|
2024
Q2 | $9.37K | Hold |
570
| – | – | ﹤0.01% | 492 |
|
|
2024
Q1 | $2.32K | Hold |
570
| – | – | ﹤0.01% | 549 |
|
|
2023
Q4 | $2.28K | Hold |
570
| – | – | ﹤0.01% | 537 |
|
|
2023
Q3 | $4.07K | Sell |
570
-570
| -50% | -$4.07K | ﹤0.01% | 561 |
|
|
2023
Q2 | $8.47K | Buy |
+1,140
| New | +$8.47K | ﹤0.01% | 550 |
|